# Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-outcomes-of-immunotherapy-based-neoadjuvant-therapy-in-resectable-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jie Shen,Linping Gu,Yuwen Qi,Yaxian Yao,Shun Lü,Zhiwei Chen |
| Citations | 5 |
| DOI | 10.3389/fimmu.2023.1268251 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268251/pdf?isPublishedV2=False |
| OpenAlex ID | https://openalex.org/W4387058477 |
| PMID | 37818382 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Linping Gu](https://scholariq.org/researchers/linping-gu/)

## Paper journal

- [Frontiers in Immunology](https://scholariq.org/journals/frontiers-in-immunology/)

## Paper primary topic

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Paper topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.